Skip to content
MedsAcross

Brand family

Orladeyo

Berotralstat · BioCryst Pharmaceuticals
United States
Presentations
7
Markets
1

Orladeyo is a brand of Berotralstat marketed by BioCryst Pharmaceuticals, with 7 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Berotralstat
Brand owner
BioCryst Pharmaceuticals
Registered in
United States
Strengths and forms
110 mg capsule, 150 mg capsule, 108 mg oral pellets, 132 mg oral pellets, 150 mg oral pellets, 72 mg oral pellets, 96 mg oral pellets

All presentations

MedicineManufacturerRegisterAvailability
Orladeyo 110 mg capsuleOralBioCryst PharmaceuticalsUS FDAAvailable on request
Orladeyo 150 mg capsuleOralBioCryst PharmaceuticalsUS FDAAvailable on request
Orladeyo 108 mg oral pelletsOralBioCryst PharmaceuticalsUS FDAAvailable on request
Orladeyo 132 mg oral pelletsOralBioCryst PharmaceuticalsUS FDAAvailable on request
Orladeyo 150 mg oral pelletsOralBioCryst PharmaceuticalsUS FDAAvailable on request
Orladeyo 72 mg oral pelletsOralBioCryst PharmaceuticalsUS FDAAvailable on request
Orladeyo 96 mg oral pelletsOralBioCryst PharmaceuticalsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Orladeyo

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.